Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

Martin Fassnacht, Cristina Ronchi, Alfredo Berruti, Eric Baudin, MG Demeure, J Gilbert, H Haak, Matthias Kroiss, DI Quinn, E Hesseltine, Massimo Terzolo, TK Choueiri, S Poondru, T Fleege, R Rorig, J Chen, Andrew W. Stephens, F Worden, Gary D Hammer

Research output: Contribution to journalArticlepeer-review

174 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences